Valeant Settles One Legal Headache But Still Faces Congressional, DOJ Probes
This article was originally published in The Pink Sheet Daily
Valeant gets payment from R&O Pharmacy in litigation settlement as House Oversight Committee presses firm to explain why it is withholding certain documents.
You may also be interested in...
Specialty mail-order pharmacy Philidor was held up as an example of how Valeant was bilking patients when the usually close arrangement initially came to light; now it seems that Valeant itself was allegedly getting bilked.
Members of House Oversight Committee accuse Turing and Valeant of 'trashing' mainstream innovator companies with their drug pricing practices.
From the rise of DTC to the shadow of Caronia, Abrams, the long-time head of the Office of Prescription Drug Promotion, monitored dramatic changes in the pharmaceutical marketplace and regulatory environment. He retired from FDA on 23 October after a tenure marked as much by careful research projects and copious guidances as it was by promotional and legal upheavals.